STOCK TITAN
  1. Home
  2. News
  3. ATEC

Alphatec Holdings, Inc. - ATEC STOCK NEWS

Welcome to our dedicated page for Alphatec Holdings news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Holdings stock.

Alphatec Holdings, Inc. (ATEC) is a leading medical technology company specializing in innovative spine surgery solutions. Our primary focus is the design, development, launch, and delivery of spinal fusion products aimed at improving patient outcomes. By collaborating with spine surgeons, we create and develop products and systems that address the entire spinal fusion procedure, enhancing efficiency and effectiveness.

At Alphatec Spine, we are committed to driving growth through constant innovation. Our product portfolio includes advanced technologies such as Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion. Each of these solutions is designed to simplify surgical procedures for surgeons, ultimately leading to superior patient outcomes.

We pride ourselves on our relentless pursuit of superior outcomes. By continuously developing technologies that positively impact patient care, we strive to be at the forefront of the medical technology industry. Our mission is to improve lives by providing cutting-edge spine surgery solutions.

For more detailed information about our products and ongoing projects, please visit our website at www.alphatecspine.com.

Latest News:

  • --- Source: Alphatec Holdings, Inc.
  • ---
  • ---
  • Source: Spineology Inc.
  • ---
  • ---
News

ATEC to Present at Upcoming Conferences

Rhea-AI Summary

Alphatec Holdings, Inc. (Nasdaq: ATEC) will be participating in several investor conferences in May and June 2024. The company also granted 14,024 restricted stock units to new employees as an inducement to accepting employment, which will vest in equal annual installments on each of the first four anniversaries of the grant date, contingent on the recipient's continuous employment with ATEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.85%
Tags
conferences
-
News

ATEC to Report First Quarter Financial Results on May 7, 2024

Rhea-AI Summary
Alphatec Holdings, Inc. (Nasdaq: ATEC) will report first quarter 2024 financial results on May 7, 2024, after the market close. The Company will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET. Inducement awards were granted to 14 new employees with 16,289 restricted stock units. RSUs will vest annually over four years or fully upon a change of control.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.16%
Tags
conferences earnings
-
News

Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales

Rhea-AI Summary
Spineology Inc. appoints Emory Rooney as Executive Vice President, Sales, to drive U.S. market growth with his 20 years of spine sales experience in medical devices.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.81%
Tags
management
News

ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights

Rhea-AI Summary
Alphatec Holdings, Inc. (Nasdaq: ATEC) reports a 37% growth in total revenue for full year 2023, reaching $482 million, with an improved adjusted EBITDA margin. Expectations for full year 2024 revenue approximate $595 million, anticipating a 23% growth compared to 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.87%
Tags
earnings
-
News

ATEC to Present at Upcoming Conferences

Rhea-AI Summary
Alphatec Holdings, Inc. (Nasdaq: ATEC) announced its participation in upcoming investor conferences and the presentation of an updated long-range financial plan. The company also disclosed the approval of inducement awards for 58 new employees in the form of restricted stock units (RSUs).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.58%
Tags
conferences
-
News

ATEC Announces Record Preliminary Revenue Results for 2023 and 2024 Revenue Guidance

Rhea-AI Summary
Alphatec Holdings, a provider of innovative solutions for spine surgery, reported a 37% increase in total revenue to over $480 million for full-year 2023. The company expects total revenue of $595 million for full-year 2024. Surgical revenue for the fourth quarter ended December 31, 2023, was in the range of $121.8M to $122.8M, with total revenue in the range of $136.8M to $138.4M. The company's continued strong momentum in the lateral franchise fueled portfolio-wide adoption and surgical revenue growth of 39% to 40% in 2023. Surgical volume growth accelerated to 31% compared to 25% in 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.1%
Tags
none
News

ATEC to Present at the 2024 J.P. Morgan Healthcare Conference

Rhea-AI Summary
Alphatec Holdings, Inc. (Nasdaq: ATEC) will present at the J.P. Morgan Healthcare Conference on January 10, 2024, to showcase innovative solutions for spine surgery.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.72%
Tags
conferences
-
News

John Booth to Retire as CEO of Spineology Inc.

Rhea-AI Summary
Spineology Inc. (NASDAQ: SPIN) appoints Brian Snider as new CEO, effective November 13, 2023, following John Booth's retirement. Snider brings nearly 20 years of experience in the medical device industry, previously serving as Executive VP of Marketing for Alphatec Spine. The Board of Directors expressed confidence in Snider's ability to lead the company's growth and surgical advancement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.26%
Tags
none
-
News

ATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA Guidance

Rhea-AI Summary
Alphatec Holdings, Inc. (Nasdaq: ATEC) reported strong financial results for the quarter ended September 30, 2023. Total revenue grew 32% to $118 million, with surgical revenue growing 32% to $104 million and EOS revenue growing 30% to $14 million. The company delivered positive adjusted EBITDA of over $2 million and ended the quarter with a cash balance of $123 million. Recent highlights include the launch of Calibrate LTXTM, a lateral expandable implant system, a 24% increase in surgical volume, and a 6% increase in average revenue per procedure. Alphatec also secured $150 million in capital to accelerate investment in revenue-generating assets and enhanced its Board of Directors with deep spine expertise.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.24%
Tags
earnings
News

ATEC to Participate in Upcoming Investor Conferences

Rhea-AI Summary
Alphatec Holdings, Inc. (Nasdaq: ATEC) will participate in several upcoming investor events, including the Stifel Healthcare Conference, the Jefferies London Healthcare Conference, the Piper Sandler Healthcare Conference, the Truist Securities MedTech West Coast Bus Tour, and the Stifel Medtech Madness West Coast Bus Tour. Webcasts and archived recordings of the conference presentations will be available on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.27%
Tags
conferences

FAQ

What is the current stock price of Alphatec Holdings (ATEC)?

The current stock price of Alphatec Holdings (ATEC) is $9.35 as of December 20, 2024.

What is the market cap of Alphatec Holdings (ATEC)?

The market cap of Alphatec Holdings (ATEC) is approximately 1.3B.

What does Alphatec Holdings, Inc. specialize in?

Alphatec Holdings, Inc. specializes in the design, development, and delivery of innovative spine surgery solutions aimed at improving patient outcomes.

What are some of the key technologies developed by Alphatec Spine?

Key technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion.

How does Alphatec Holdings, Inc. improve spine surgery procedures?

Alphatec collaborates with spine surgeons to create products that simplify spinal fusion procedures, making them more effective and efficient.

What is the mission of Alphatec Holdings, Inc.?

The mission is to improve lives by providing innovative spine surgery solutions through relentless pursuit of superior outcomes.

How does Alphatec Holdings, Inc. drive growth?

Alphatec drives growth through continuous innovation and development of technologies that positively impact patient care.

Where can I find more information about Alphatec Holdings, Inc.?

More information can be found on their website: www.alphatecspine.com.

What recent achievements has Alphatec Holdings, Inc. made?

For the latest achievements and developments, please refer to the news section on their website or check financial news sources.

What are the main products of Alphatec Holdings, Inc.?

The main products include various spine surgery technologies such as Posterior Cervical Fusion and Lateral Interbody Fusion.

How does Alphatec Holdings, Inc. ensure superior patient outcomes?

By developing innovative technologies and working closely with spine surgeons to improve surgical procedures.

Is Alphatec Holdings, Inc. involved in any partnerships?

Yes, Alphatec collaborates with spine surgeons and other stakeholders to enhance their product offerings and improve surgical outcomes.

Stock ATEC logo
Alphatec Holdings, Inc.

Nasdaq:ATEC

ATEC Rankings

#2331 Ranked by Market Cap
N/A Ranked by Dividends

ATEC Stock Data

1.27B
105.57M
25.47%
57.93%
7.47%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
CARLSBAD